NEUROBLASTOMA RECURRENT
Clinical trials for NEUROBLASTOMA RECURRENT explained in plain language.
Never miss a new study
Get alerted when new NEUROBLASTOMA RECURRENT trials appear
Sign up with your email to follow new studies for NEUROBLASTOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill combo offers hope for kids with tough cancers
Disease control Recruiting nowThis study is testing a new combination of two oral drugs, AMXT 1501 and eflornithine (DFMO), for children and young adults with certain hard-to-treat cancers that have come back or not responded to standard treatments. The first part of the study aims to find the safest and most…
Matched conditions: NEUROBLASTOMA RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Apr 04, 2026 00:21 UTC
-
New hope for tough childhood cancer: boosting immune attack on neuroblastoma
Disease control Recruiting nowThis study is testing whether adding an experimental immune-boosting drug called N-803 to a standard chemoimmunotherapy regimen works better for treating neuroblastoma that has returned or is not responding to prior therapy. It will involve about 54 children and young adults unde…
Matched conditions: NEUROBLASTOMA RECURRENT
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Four-Pronged attack on tough childhood cancer
Disease control Recruiting nowThis study is testing a combination of four different immune-based treatments to see if they can help control neuroblastoma in children when the cancer has returned or not responded to standard therapies. The treatment involves donor immune cells, a targeted antibody, immune-boos…
Matched conditions: NEUROBLASTOMA RECURRENT
Phase: PHASE2 • Sponsor: Hong Kong Children's Hospital • Aim: Disease control
Last updated Feb 27, 2026 15:18 UTC